# BBLGW (Bone Biologics Corporation) - SEC EDGAR Financial Statements

> Bone Biologics Corporation reported $6.43M in total assets and a net loss of $2.84M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BBLGW
- Markdown: https://convexityos.com/fundamentals/BBLGW.md
- SEC CIK: 0001419554
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:05 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001419554&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$3.01M | Operating profit |
| Net Income | FY 2025 | -$2.84M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.76 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $6.09M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | $1.07B | $1.07B | -- | -- | -- |
| Research & Development | $1.06M | $2.13M | $6.91M | $1.58M | $82K | $341K | $1.10M | $104K | $1.42M | $10.17M |
| Total Operating Expenses | $3.23M | $4.22M | $9.43M | $3.67M | $1.10M | $825K | $2.45M | $2.79M | $2.63M | $20.41M |
| **Operating Income** | -$3.23M | -$4.22M | -$9.43M | -$3.67M | -$1.10M | -$825K | -$2.45M | -$2.79M | -$2.63M | -$20.41M |
| **EBITDA** | -- | -- | -- | -- | -- | -- | -$2.45M | -$2.79M | -$2.63M | -$20.41M |
| Interest Income | $122K | $56K | $1.9K | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -- | -- | -- | -- | -$1.61M | -$1.82M | -$3.42M | -$4.43M | -$7.05M | -$25.88M |
| Income Tax Expense | -- | -- | -- | -- | $1.6K | $1.6K | $1.6K | $1.7K | $1.6K | $2.2K |
| **Net Income** | -$3.11M | -$4.11M | -$8.95M | -$1.48M | -$1.61M | -$1.82M | -$3.42M | -$4.43M | -$7.05M | -$25.88M |
| Basic EPS | -$2.65 | -$28.96 | -$204.26 | -$2,957,304.83 | -$997,842.17 | -$1,796,115.90 | -$1,339,959.48 | -$2,508,860.31 | -$5,160,269.50 | -$1,967,174.56 |
| **Diluted EPS** | -$2.65 | -$28.96 | -$204.26 | -$2,957,304.83 | -$997,842.17 | -$1,796,115.90 | -$1,339,959.48 | -$2,508,860.31 | -$5,160,269.50 | -$1,967,174.56 |
| Basic Shares Outstanding | 1.2M | 253.0K | 43.8K | 1 | 2 | 1 | 3 | 2 | 1 | 13 |
| Diluted Shares Outstanding | 1.2M | 253.0K | 43.8K | 1 | 2 | 1 | 3 | 2 | 1 | 13 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $243K | $309K | $142K | $257K | $188K | $192K | $424K | $1.10M |
| Total Operating Expenses | $666K | $808K | $805K | $733K | $715K | $748K | $1.04M | $1.55M |
| **Operating Income** | -$666K | -$808K | -$805K | -$733K | -$715K | -$748K | -$1.04M | -$1.55M |
| Interest Income | $48K | $35K | $39K | $48K | $47K | $6.7K | $20K | $20K |
| **Net Income** | -$618K | -$774K | -$766K | -$685K | -$667K | -$741K | -$1.02M | -$1.52M |
| Basic EPS | -$0.17 | -$0.43 | -$0.43 | -- | -$0.37 | -$1.33 | -$1.92 | -- |
| **Diluted EPS** | -$0.17 | -$0.43 | -$0.43 | -- | -$0.37 | -$1.33 | -$1.92 | -- |
| Basic Shares Outstanding | 3.7M | 1.8M | 1.8M | -- | 1.8M | 557.8K | 530.6K | -- |
| Diluted Shares Outstanding | 3.7M | 1.8M | 1.8M | -- | 1.8M | 557.8K | 530.6K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.33M | $3.33M | $3.03M | $7.54M | $6.68M | -- | $24K | $955K | $690K | $1.62M |
| **Cash & Short-Term Investments** | $5.33M | $3.33M | $3.03M | $7.54M | $6.68M | -- | $24K | $955K | $690K | $1.62M |
| **Total Current Assets** | $5.80M | $3.86M | $3.74M | $8.50M | -- | -- | $31K | $1.04M | $796K | $1.67M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | -- | $50 | $146 | $170 |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | -- | -- | $0 | $50 | $146 | $170 |
| **Total Assets** | $5.80M | $3.86M | $3.74M | $8.50M | $6.68M | $0 | $31K | $1.04M | $796K | $1.67M |
| Accounts Payable | -- | -- | -- | -- | -- | $465K | $43K | $125K | $217K | $225K |
| **Total Current Liabilities** | $419K | $378K | $831K | $2.55M | $100K | $13.69M | $578K | $9.64M | $962K | $3.82M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $11.32M | $0 | $8.23M | $8.03M |
| **Total Liabilities** | $419K | $378K | $831K | $2.55M | $100K | $13.69M | $11.90M | $9.64M | $9.19M | $11.85M |
| Common Stock | $1.8K | $492 | $534 | $64 | $10K | $12K | $31K | $26K | $4.3K | $39K |
| Retained Earnings | -$88.13M | -$85.02M | -$80.91M | -$71.96M | -$70.48M | -$68.86M | -$67.04M | -$63.62M | -$59.19M | $56.42M |
| **Total Stockholders' Equity** | $5.38M | $3.48M | $2.91M | $5.95M | $6.58M | -$13.69M | -$11.87M | -$8.60M | -$8.40M | -$10.18M |
| Total Equity | $5.38M | $3.48M | $2.91M | $5.95M | $6.58M | -$13.69M | -$11.87M | -$8.60M | -$8.40M | -$10.18M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $6.09M | $4.03M | $4.53M | $5.33M | $6.05M | $6.64M | $2.75M | $3.33M |
| **Cash & Short-Term Investments** | $6.09M | $4.03M | $4.53M | $5.33M | $6.05M | $6.64M | $2.75M | $3.33M |
| **Total Current Assets** | $6.43M | $4.44M | $4.98M | $5.80M | $6.35M | $7.00M | $3.16M | $3.86M |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $6.43M | $4.44M | $4.98M | $5.80M | $6.35M | $7.00M | $3.16M | $3.86M |
| **Total Current Liabilities** | $481K | $512K | $309K | $419K | $334K | $406K | $251K | $378K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $481K | $512K | $309K | $419K | $334K | $406K | $251K | $378K |
| Common Stock | $3.4K | $1.8K | $1.8K | $1.8K | $1.8K | $1.7K | $3.3K | $492 |
| Retained Earnings | -$90.29M | -$89.67M | -$88.90M | -$88.13M | -$87.45M | -$86.78M | -$86.04M | -$85.02M |
| **Total Stockholders' Equity** | $5.95M | $3.92M | $4.67M | $5.38M | $6.02M | $6.60M | $2.91M | $3.48M |
| Total Equity | $5.95M | $3.92M | $4.67M | $5.38M | $6.02M | $6.60M | $2.91M | $3.48M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.10M | -$4.11M | -$8.95M | -$1.48M | -$1.61M | -$1.82M | -$3.42M | -$4.43M | -$7.05M | -$25.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | $50 | $96 | $96 | $700 |
| Stock-Based Compensation | $256K | $189K | $153K | $267K | $207K | -- | $50K | $517K | $1.62M | $4.14M |
| **Operating Cash Flow** | -$2.69M | -$4.12M | -$9.56M | -$3.57M | -$1.23M | -$427K | -$3.25M | -$4.10M | -$3.33M | -$7.33M |
| Common Stock Issued | $4.35M | $1.50M | $5.04M | $4.43M | $6.86M | -- | -- | $4.37M | $700K | $2.50M |
| **Financing Cash Flow** | $4.70M | $4.42M | $5.04M | $4.43M | $7.90M | $403K | $2.32M | $4.37M | $3.40M | $6.83M |
| **Net Change in Cash** | $2.01M | $299K | -$4.51M | $863K | $6.68M | -$24K | -$931K | $265K | $70K | -$495K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$700K | -$700K | -$800K | -$685K | -$667K | -$741K | -$1.02M | -$1.52M |
| Stock-Based Compensation | $3.4K | $8.3K | $24K | $46K | $87K | $73K | $51K | $101K |
| **Operating Cash Flow** | -$532K | -$518K | -$804K | -$715K | -$591K | -$459K | -$926K | -$1.35M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | -- | -- | -- | $0 | $0 | $4.35M | $348K | $1.11M |
| **Net Change in Cash** | $2.06M | -$498K | -$804K | -$715K | -$591K | $3.89M | -$579K | -$241K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -0.1% | -0.2% | -- | -- | -- |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -0.2% | -0.3% | -- | -- | -- |
| Return on Equity (ROE) | -57.8% | -118.0% | -307.9% | -25.0% | -24.5% | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -53.6% | -106.5% | -239.4% | -17.5% | -24.1% | -- | -11109.8% | -425.7% | -886.3% | -3690.9% |
| Current Ratio | 13.85x | 10.22x | 4.50x | 3.33x | -- | -- | 0.05x | 0.11x | 0.83x | 0.47x |
| Quick Ratio | 12.74x | 8.80x | 3.64x | 2.96x | 66.81x | -- | 0.04x | 0.10x | 0.72x | 0.41x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | 0.0% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -47.8% | -73.7% | -61.2% | -57.8% | -65.6% | -64.0% | -146.5% | -118.0% |
| Return on Assets (ROA) | -44.2% | -65.2% | -57.4% | -53.6% | -62.1% | -60.3% | -134.8% | -106.5% |
| Current Ratio | 13.38x | 8.67x | 16.09x | 13.85x | 19.00x | 17.24x | 12.59x | 10.22x |
| Quick Ratio | 12.66x | 7.87x | 14.64x | 12.74x | 18.10x | 16.35x | 10.94x | 8.80x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
